WINDLASNSEWindlas Biotech LimitedLowNeutral
Announced Thu, 21 May · 10:53 IST

Manoj Kumar Windlass has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

WINDLAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.4%1-day move
₹798.95
prior close
₹788.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.2+0.5+0.1-2.4-1.8+2.6+2.8+3.5+1.0+3.9+6.5+10.2
Up moveDown movePending
AI summary

Promoter Manoj Kumar Windlass has filed a declaration confirming that neither he nor any persons acting in concert have created any new encumbrances (pledges) on Windlas Biotech shares during FY 2025-26, beyond what has already been disclosed. This is a negative declaration under Regulation 31(4), essentially stating 'no new pledges' during the period. The filing covers the entire promoter group including Ashok Kumar Windlass (44,00,000 shares), Vimla Windlass (2,84,000 shares), and AKW WBL Family Private Trust (83,81,340 shares), totalling 1,30,65,352 shares across 7 entities.

Likely market impact

This is a routine compliance filing that carries no immediate negative signal. It provides transparency that no additional promoter share pledging occurred during the financial year, which is generally viewed positively by the market as it indicates promoters are not using shares as collateral.